You are reading a single comment by @Petteri and its replies.
Click here to read the full conversation.
-
The latest consensus from north Italy is just that tocilizumab might have a theoretical benefit. It isn’t without side effects and there are difficult decisions about when to use it. If you’re a mild/moderate case who is likely to recover, why risk it. Equally if you’re critically ill on ITU and at huge risk of superinfection, are we really so sure that it works that we’ll risk immunosuppression. Not convinced it’ll be making its way into the treatment guidelines in the UK.
charliem
@Petteri
Copious amounts of G and T won´t help if you take ill but:
http://www.ansa.it/english/news/science_tecnology/2020/03/11/coronavirusarthritis-drug-seems-to-work_8113f9d9-9bb8-4181-9c02-3e314c30e7e9.html
https://en.wikipedia.org/wiki/Tocilizumab